RU2016107813A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2016107813A3 RU2016107813A3 RU2016107813A RU2016107813A RU2016107813A3 RU 2016107813 A3 RU2016107813 A3 RU 2016107813A3 RU 2016107813 A RU2016107813 A RU 2016107813A RU 2016107813 A RU2016107813 A RU 2016107813A RU 2016107813 A3 RU2016107813 A3 RU 2016107813A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361863659P | 2013-08-08 | 2013-08-08 | |
| US61/863,659 | 2013-08-08 | ||
| US201361912856P | 2013-12-06 | 2013-12-06 | |
| US61/912,856 | 2013-12-06 | ||
| US201461987664P | 2014-05-02 | 2014-05-02 | |
| US61/987,664 | 2014-05-02 | ||
| PCT/IB2014/063781 WO2015019320A1 (en) | 2013-08-08 | 2014-08-07 | Pim kinase inhibitor combinations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2016107813A RU2016107813A (ru) | 2017-09-14 |
| RU2016107813A3 true RU2016107813A3 (ru) | 2018-05-23 |
Family
ID=51355592
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2016107813A RU2016107813A (ru) | 2013-08-08 | 2014-08-07 | Комбинации ингибиторов киназы pim |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20160175293A1 (ru) |
| EP (1) | EP3030237A1 (ru) |
| JP (2) | JP2016527305A (ru) |
| KR (1) | KR20160040196A (ru) |
| CN (1) | CN105611928A (ru) |
| AU (3) | AU2014304126A1 (ru) |
| BR (1) | BR112016002311A2 (ru) |
| CA (1) | CA2917936A1 (ru) |
| HK (1) | HK1222539A1 (ru) |
| MX (1) | MX2016001683A (ru) |
| RU (1) | RU2016107813A (ru) |
| WO (1) | WO2015019320A1 (ru) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2671748T3 (es) | 2011-07-21 | 2018-06-08 | Tolero Pharmaceuticals, Inc. | Inhibidores heterocíclicos de proteína quinasas |
| US10525047B2 (en) | 2016-03-25 | 2020-01-07 | University Of Maryland, Baltimore County | PIM kinase inhibitors in combination with RNA splicing modulators/inhibitors for treatment of cancers |
| AR113922A1 (es) | 2017-12-08 | 2020-07-01 | Incyte Corp | Terapia de combinación de dosis baja para el tratamiento de neoplasias mieloproliferativas |
| US20210113562A1 (en) * | 2018-04-13 | 2021-04-22 | Sumitomo Dainippon Pharma Oncology, Inc. | Pim kinase inhibitors for treatment of myeloproliferative neoplasms and fibrosis associated with cancer |
| EP3856189A4 (en) * | 2018-09-25 | 2022-06-29 | Impact Biomedicines, Inc. | Methods of treating myeloproliferative disorders |
| CA3127502A1 (en) | 2019-02-12 | 2020-08-20 | Sumitomo Dainippon Pharma Oncology, Inc. | Formulations comprising heterocyclic protein kinase inhibitors |
| WO2024097653A1 (en) | 2022-10-31 | 2024-05-10 | Sumitomo Pharma America, Inc. | Pim1 inhibitor for treating myeloproliferative neoplasms |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO2660B1 (en) | 2006-01-20 | 2012-06-17 | نوفارتيس ايه جي | Pi-3 inhibitors and methods of use |
| RS54506B1 (en) * | 2008-09-02 | 2016-06-30 | Novartis Ag | PICOLINAMIDE DERIVATIVES AS KINASE INHIBITORS |
| UA104147C2 (ru) | 2008-09-10 | 2014-01-10 | Новартис Аг | Производная пирролидиндикарбоновой кислоты и ее применение в лечении пролиферативных заболеваний |
| US20130244963A1 (en) * | 2010-09-30 | 2013-09-19 | Portola Pharmaceuticals, Inc. | Combination therapy with 4-(3-(2h-1,2,3-triazol-2-yl)phenylamino)-2-((1r,2s)-2-aminocyclohexylamino)pyrimidine-5-carboxamide |
-
2014
- 2014-08-07 EP EP14752432.6A patent/EP3030237A1/en not_active Withdrawn
- 2014-08-07 JP JP2016532783A patent/JP2016527305A/ja not_active Withdrawn
- 2014-08-07 MX MX2016001683A patent/MX2016001683A/es unknown
- 2014-08-07 CN CN201480055396.8A patent/CN105611928A/zh active Pending
- 2014-08-07 CA CA2917936A patent/CA2917936A1/en not_active Abandoned
- 2014-08-07 RU RU2016107813A patent/RU2016107813A/ru not_active Application Discontinuation
- 2014-08-07 US US14/910,381 patent/US20160175293A1/en not_active Abandoned
- 2014-08-07 KR KR1020167003069A patent/KR20160040196A/ko not_active Application Discontinuation
- 2014-08-07 AU AU2014304126A patent/AU2014304126A1/en not_active Abandoned
- 2014-08-07 BR BR112016002311A patent/BR112016002311A2/pt active Search and Examination
- 2014-08-07 WO PCT/IB2014/063781 patent/WO2015019320A1/en active Application Filing
-
2016
- 2016-09-07 HK HK16110653.9A patent/HK1222539A1/zh unknown
-
2017
- 2017-08-01 AU AU2017210520A patent/AU2017210520A1/en not_active Abandoned
- 2017-09-07 US US15/698,045 patent/US20170368044A1/en not_active Abandoned
-
2018
- 2018-10-19 JP JP2018197073A patent/JP2019038821A/ja active Pending
-
2019
- 2019-02-20 AU AU2019201169A patent/AU2019201169A1/en not_active Abandoned
- 2019-06-14 US US16/441,418 patent/US20190290627A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20160175293A1 (en) | 2016-06-23 |
| WO2015019320A1 (en) | 2015-02-12 |
| CN105611928A (zh) | 2016-05-25 |
| HK1222539A1 (zh) | 2017-07-07 |
| RU2016107813A (ru) | 2017-09-14 |
| AU2019201169A1 (en) | 2019-03-07 |
| MX2016001683A (es) | 2016-05-02 |
| CA2917936A1 (en) | 2015-02-12 |
| AU2014304126A1 (en) | 2016-02-11 |
| JP2019038821A (ja) | 2019-03-14 |
| US20190290627A1 (en) | 2019-09-26 |
| BR112016002311A2 (pt) | 2017-08-01 |
| KR20160040196A (ko) | 2016-04-12 |
| EP3030237A1 (en) | 2016-06-15 |
| AU2017210520A1 (en) | 2017-08-17 |
| US20170368044A1 (en) | 2017-12-28 |
| JP2016527305A (ja) | 2016-09-08 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA94 | Acknowledgement of application withdrawn (non-payment of fees) |
Effective date: 20201124 |